RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 157 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.96 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,449,568 | +2.4% | 5,941,120 | 0.0% | 43.00% | +30.9% |
| Q2 2023 | $44,380,166 | +12.0% | 5,941,120 | 0.0% | 32.86% | -22.2% |
| Q1 2023 | $39,627,270 | -13.5% | 5,941,120 | 0.0% | 42.23% | -12.2% |
| Q4 2022 | $45,806,035 | -27.5% | 5,941,120 | 0.0% | 48.11% | -3.7% |
| Q3 2022 | $63,214,000 | +30.7% | 5,941,120 | 0.0% | 49.97% | +25.1% |
| Q2 2022 | $48,361,000 | +13.7% | 5,941,120 | 0.0% | 39.94% | +342.4% |
| Q1 2022 | $42,538,000 | -58.2% | 5,941,120 | 0.0% | 9.03% | -34.3% |
| Q4 2021 | $101,771,000 | – | 5,941,120 | – | 13.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $79,603,360 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $45,449,568 | 43.00% |
| MIC Capital Management UK LLP | 8,451,758 | $64,655,952 | 14.74% |
| MV Management XI, L.L.C. | 788,762 | $6,034,029 | 10.04% |
| ArchPoint Investors | 1,047,386 | $8,012,503 | 3.06% |
| Connective Portfolio Management, LLC | 33,000 | $252,000 | 0.77% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,335,132 | $17,863,760 | 0.70% |
| Diametric Capital, LP | 136,331 | $1,042,932 | 0.44% |
| ARK Investment Management | 6,876,598 | $52,605,973 | 0.40% |
| ALLEN OPERATIONS LLC | 217,657 | $1,665,076 | 0.37% |